Physician profile
Jayla Smith
NPI 1922622372
$616.77
in general payments reported to CMS, 2019-2025
14 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $203 · 2023: $115 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.00 | 2022 | |
| Glaxosmithkline, LLC. | $85.10 | 2021 | |
| Janssen Scientific Affairs, LLC | $79.91 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $69.70 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $64.40 | 2022-2023 | Xarelto |
| Lilly USA, LLC | $40.86 | 2025 | Mounjaro |
| Teva Pharmaceuticals USA, INC. | $33.03 | 2025 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $29.33 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.31 | 2022 | |
| Bioventus LLC | $20.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.21 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $19.30 | 2025 | |
| Exact Sciences Corporation | $18.09 | 2025 | The Cologuard Plus Collection Kit |
| Allergan, INC. | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayla Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.